[3]趙博文,應(yīng)可凈,陳麗英等.彩色多普勒超聲檢查在急性肺栓塞診斷與治療中的價(jià)值[J].中華急診醫(yī)學(xué)雜志,2006,15(4)
[4]江立斌,應(yīng)可凈.右室功能異常對(duì)血壓正常肺栓塞預(yù)后影響[J].中華內(nèi)科雜志,2007,46(2)
[5]陳麗英,倪虹.深靜脈血栓形成的防治對(duì)策[J].全科醫(yī)學(xué)臨床與教育,2003,1(3)
[6]陳麗英,應(yīng)可凈,虞振委等.膀胱癌并發(fā)反復(fù)靜脈血栓1例[J].
中國腫瘤臨床,2006,33(11)
[7]應(yīng)可凈.肺癌合并
肺血栓栓塞癥5例結(jié)合文獻(xiàn)復(fù)習(xí)[J].實(shí)用腫瘤雜志,2006,21(2)
[8]應(yīng)可凈,陳麗英.低分子
肝素和普通肝素治療急性肺血栓栓塞癥的比較[J].中華急診醫(yī)學(xué)雜志,2004,13(5)
[9]周勇,應(yīng)可凈,章迎春等.24例急性致死性肺血栓栓塞患者的分析[J].中華急診醫(yī)學(xué)雜志,2006,15(3)
[10]朱志俊,方素華
m.payment-defi.com,王敏珍等.圍手術(shù)期干預(yù)對(duì)婦科盆腔手術(shù)后下肢深靜脈血栓的預(yù)防作用[J].
中華婦產(chǎn)科雜志,2009,44(9)
[11]應(yīng)可凈.急性肺血栓栓塞癥診斷預(yù)測方法的研究[J].中華急診醫(yī)學(xué)雜志,2006,15(11)
[12]Multiple myeloma with pulmonary embolism: a case report.chinese medical journal,2006,vol.119 No 17:1481-1483. YING Ke-jing, ZHOU Yong*, JIANG Hao, CHEN En-guo, ZHOU Pan
[13]24例急性致死性肺血栓栓塞患者的分析;中華急診醫(yī)學(xué)雜志;2006.3;15(3);243-245; 周勇、應(yīng)可凈*、章迎春、陳麗英
[14]非人類免疫缺陷病毒感染者肺
隱球菌病14例影像學(xué)分析;
中華放射學(xué)雜志;2006:40(1); 104-105; 應(yīng)可凈、江立斌、胡紅杰、陳恩國、洪武軍.
[15]Comparison of low-molecular-weight-heparin and unfractionated heparin for acute PTE;浙江大學(xué)學(xué)報(bào)英文版;2005.12; 6(12): 1195–1199;CHEN Li-ying , YING Ke-jing*, HONG Wu-jun , ZHOU Pan
[16]肺癌活檢組織中Polo樣激酶-1 mRNA水平檢測的臨床意義.
中華檢驗(yàn)醫(yī)學(xué)雜志;2006.9;29(9);813-816; 應(yīng)可凈、邵方淳*、余碧蕓、吳金民、丁佳逸
[17]
肺隱球菌病九例分析;
中華結(jié)核和呼吸雜志. 2005 Jul;28(7):464-7.應(yīng)可凈，江立斌*.
[18]右室功能異常對(duì)血壓正常肺栓塞預(yù)后影響；中華內(nèi)科雜志；2007.46（2),111-113; 江立斌*、應(yīng)可凈
[19]
發(fā)熱-皮疹-淋巴結(jié)腫大-氣急-彌漫性出血；
中華醫(yī)學(xué)雜志；2004.7；84（14)；1225-1227；應(yīng)可凈、余碧蕓、洪武軍
m.payment-defi.com、金春蘭
[20]Ruan W, Ying K.Abnormal expression of IGF-binding proteins, an initiating event in idiopathic pulmonary fibrosis?Pathol Res Pract. 2010 Aug 15;206(8):537-43. Epub 2010 May 7.
[21]Zhang R, Shao F, Wu X, Ying K.Value of quantitative analysis of circulating cell free DNA as a screening tool for lung cancer: A meta-analysis.Lung Cancer. 2010 Aug;69(2):225-231. Epub 2009 Dec 11.
[22]Hu YJ, Qiu YH, Chen EG, Ying KJ, Yu J, Wang P.[Determination of volatile organic compounds in lung cancer cell lines and lung cancer tissue.]Zhejiang Da Xue Xue Bao Yi Xue Ban. 2010 May;39(3):278-84. Chinese.
[23].Lu CR, Hu YJ, Chen EG, Qiu YH, Ying KJ.[Measurement of exhaled volatile organic compounds in lung cancer patients.]Zhonghua Jie He He Hu Xi Za Zhi. 2010 Feb;33(2):104-8. Chinese.
在研課題：
[1]次大面積肺血栓栓塞癥溶栓抗凝與單純抗凝治療的療效與安全性評(píng)價(jià)：多中心隨機(jī)對(duì)照試驗(yàn)
[2]肺癌人群中VTE流行病學(xué)調(diào)查（前瞻性、多中心)
[3]COPD急性加重期VTE發(fā)病情況及凝血功能研究
[4]肺血栓栓塞癥患者診治及預(yù)后的注冊(cè)登記研究
上一頁 [1] [2] [3] [4] 下一頁
